Compass Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 16.79 M | $90.17 M | -0.13% | 12.14% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 15.22 M | $81.73 M | 0.00% | 11.01% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 14.18 M | $76.16 M | 0.58% | 10.26% |
| VIVO CAPITAL, LLC | 02/13/2026 | 9.55 M | $51.26 M | 0.00% | 6.90% |
| BLACKROCK, INC. | 02/12/2026 | 9.39 M | $50.42 M | 27.38% | 6.79% |
| VANGUARD GROUP INC | 01/29/2026 | 8.05 M | $43.22 M | 13.95% | 5.82% |
| ENAVATE SCIENCES GP, LLC | 02/17/2026 | 7.79 M | $41.82 M | 0.00% | 5.63% |
| BVF INC/IL | 02/17/2026 | 7.76 M | $41.70 M | 63.47% | 5.62% |
| BLACKSTONE INC. | 02/17/2026 | 6.13 M | $32.90 M | -37.74% | 4.43% |
| STATE STREET CORP | 02/13/2026 | 4.89 M | $26.26 M | 57.43% | 3.54% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 4.44 M | $23.82 M | -14.46% | 3.21% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 3.93 M | $21.09 M | -12.24% | 2.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 3.61 M | $19.36 M | 100.00% | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.50 M | $18.81 M | 18.95% | 2.53% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/20/2026 | 3.47 M | $18.62 M | 33.76% | 2.51% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 3.37 M | $18.07 M | 65.88% | 2.43% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.11 M | $16.70 M | -3.96% | 2.25% |
| BRAIDWELL LP | 02/17/2026 | 2.79 M | $14.96 M | 100.00% | 2.02% |
| FMR LLC | 02/17/2026 | 2.58 M | $13.85 M | -37.65% | 1.87% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 2.53 M | $13.60 M | 100.00% | 1.83% |
| RTW INVESTMENTS, LP | 02/17/2026 | 2.50 M | $13.43 M | 0.00% | 1.81% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.59 M | $8.56 M | -43.63% | 1.15% |
| BIRCHVIEW CAPITAL, LP | 02/13/2026 | 1.59 M | $8.55 M | 82.48% | 1.15% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.52 M | $8.15 M | 45.95% | 1.10% |
| 02/17/2026 | 1.42 M | $7.60 M | 100.00% | 1.02% | |
| MARSHALL WACE, LLP | 02/13/2026 | 1.26 M | $6.79 M | 100.00% | 0.91% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.15 M | $6.18 M | -43.90% | 0.83% |
| 02/13/2026 | 1.11 M | $5.98 M | 100.00% | 0.81% | |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 1.09 M | $5.87 M | 30.14% | 0.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.05 M | $5.65 M | -62.90% | 0.76% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/12/2026 | 1.00 M | $5.37 M | -20.00% | 0.72% |
| NORTHERN TRUST CORP | 02/17/2026 | 972.94 K | $5.22 M | 12.88% | 0.70% |
| JPMORGAN CHASE & CO | 02/11/2026 | 870.01 K | $4.67 M | -56.48% | 0.63% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 823.17 K | $4.42 M | 100.00% | 0.60% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 800.00 K | $4.30 M | 100.00% | 0.58% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 700.00 K | $3.76 M | 0.00% | 0.51% |
| BARCLAYS PLC | 02/13/2026 | 594.78 K | $3.19 M | 167.41% | 0.43% |
| HEALTHINVEST PARTNERS AB | 02/06/2026 | 584.33 K | $3.14 M | 100.00% | 0.42% |
| 04/02/2026 | 568.75 K | $3.05 M | 100.00% | 0.41% | |
| Y-INTERCEPT (HONG KONG) LTD | 02/13/2026 | 462.17 K | $2.48 M | 100.00% | 0.33% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 452.44 K | $2.43 M | -5.01% | 0.33% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 441.81 K | $2.37 M | 100.00% | 0.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 410.16 K | $2.20 M | 22.34% | 0.30% |
| MORGAN STANLEY | 02/13/2026 | 365.25 K | $1.96 M | 95.37% | 0.26% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 341.60 K | $1.83 M | 94.58% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 316.85 K | $1.70 M | -0.40% | 0.23% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 314.75 K | $1.69 M | 100.00% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 312.48 K | $1.68 M | 40.02% | 0.23% |
| NUVEEN, LLC | 02/12/2026 | 288.92 K | $1.55 M | 11.46% | 0.21% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 285.99 K | $1.54 M | 100.00% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Compass Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 204 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 2.39 M
ROYCE & ASSOCIATES LP: 1.62 M
Fisher Asset Management, LLC: 1.35 M
VANGUARD FIDUCIARY TRUST CO: 998,140
Y-Intercept (Hong Kong) Ltd: 828,879
CITIGROUP INC: 598,238
118.67% of Compass Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 179.92 M shares in the last 24 months. This purchase volume represents approximately $975.18 M in transactions.